LDLR and metabolic dysfunction-associated steatohepatitis: We examined whether the pathological changes in the liver were attenuated by KRX-104130 in a methionine–choline-deficient (MCD) diet induced NASH mouse model because a recent study showed that upregulation of hepatic LDLR is associated with amelioration of MCD-induced NASH features [30].